Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine.

Nature communications·2022
Same author

Exosome Release by Glucose Deprivation Is Important for the Viability of TSC-Null Cells.

Cells·2022
Same author

O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine.

Nature communications·2022
Same author

Oridonin Attenuates Cisplatin-Induced Acute Kidney Injury via Inhibiting Oxidative Stress, Apoptosis, and Inflammation in Mice.

BioMed research international·2022
Same author

Platform- and label-free detection of lead ions in environmental and laboratory samples using G-quadraplex probes by circular dichroism spectroscopy.

Scientific reports·2020
Same author

RecA requires two molecules of Mg2+ ions for its optimal strand exchange activity in vitro.

Nucleic acids research·2018

Related Experiment Video

Updated: Jul 27, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

782

Engineered Extracellular Vesicles with Compound-Induced Cargo Delivery to Solid Tumors.

Raeyeong Kim1, Jong Hyun Kim1

  • 1Department of Biochemistry, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.

International Journal of Molecular Sciences
|June 10, 2023
PubMed
Summary

Researchers developed a novel system to deliver therapeutic cargo using extracellular vesicles (EVs) and a small molecule-induced protein interaction. This method enhances EV delivery to refractory cancer cells, offering new therapeutic possibilities for difficult-to-treat cancers.

Keywords:
deliveryextracellular vesiclesprotein-protein interactionrefractory cancersmall molecules

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.6K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.2K

Related Experiment Videos

Last Updated: Jul 27, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

782
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.6K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.2K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Efficient delivery of therapeutic agents into target cells is a significant challenge in medicine.
  • Extracellular vesicles (EVs) show promise as delivery vehicles, but improved tools are needed for targeting cancer cells.
  • Refractory cancers, including triple-negative breast, non-small cell lung, and pancreatic cancers, require innovative therapeutic strategies.

Purpose of the Study:

  • To develop a novel, inducible system for delivering specific cargo via extracellular vesicles (EVs) to refractory cancer cells.
  • To utilize a small molecule-induced protein-protein interaction (PPI) to enhance EV-mediated cargo delivery.
  • To demonstrate the functional delivery of EVs loaded with therapeutic cargo to various hard-to-treat cancer cell types.

Main Methods:

  • Engineered an inducible interaction system using the FKBP12-rapamycin-binding protein (FRB) domain and FK506 binding protein (FKBP).
  • Fused CD9, an EV protein, to the FRB domain and linked specific cargo to FKBP.
  • Utilized rapamycin to induce protein-protein interactions, recruiting cargo to EVs for subsequent delivery.

Main Results:

  • Successfully demonstrated the recruitment of validated cargo to EVs through the inducible FKBP-FRB interaction system.
  • Showcased functional delivery of these engineered EVs to refractory cancer cells, including triple-negative breast cancer, non-small cell lung cancer, and pancreatic cancer cells.
  • Validated the efficacy of the small molecule-induced trafficking system for therapeutic cargo delivery.

Conclusions:

  • The developed reversible PPI-driven system provides a promising new method for enhancing EV-mediated drug delivery.
  • This functional delivery system offers novel therapeutic possibilities for combating refractory cancers.
  • The inducible nature of the system allows for controlled cargo loading and targeted delivery to cancer cells.